The effect of the interaction of these two antimicrobial agents and their fractional inhibitory concentration (FIC) on the chosen strains was studied using checkerboard method.13 The layout of the checkerboard study for one plate is shown in Fig. 1. FIC was calculated by using following formula and FIC index is the sum of FIC of each of the drug present in the plate: FIC=MICofAincombination/MICofAalone+MICofBincombination/MICofBalone FICindex=FICA+FICBwhere A is the concentration of drug A, FICA is the fractional inhibitory concentration of drug A. Similarly, B is the concentration

of drug B, FICB is the fractional inhibitory concentration of drug B. Using above method, the combination is considered synergistic A-1210477 cell line when Cabozantinib mouse the FIC index is ≤0.5, additive when the FIC index is >0.5 to <2, and antagonistic when the FIC index is ≥2. We also estimated FICImin and FICImax. The MIC was determined by agar dilution method following

the method of the CLSI guidelines.14 AST was determined by the cup-plate agar diffusion method as described earlier.15 30 μl of the drug preparation CVA1020 (vancomycin with l-arginine + ceftriaxone (30:30 μg), vancomycin (30 μg) and ceftriaxone (30 μg)) was placed into the wells and allowed the plates to incubate at 37 °C for 18 h. After incubation the zone of inhibition around the wells was measured in mm (millimeter), averaged and the mean values were recorded. TKC study was performed according to CLSI guidelines.14 Twice the MIC of vancomycin with

l-arginine and ceftriaxone (CVA1020), ceftriaxone and vancomycin alone was used for this study. The samples were removed at 0, 2, 4, 6, 8, 10 and 12 h and were diluted and plated on MHA. Suplatast tosilate Synergism was defined as a 3 log decrease in cfu/ml.16 A fixed amount of l-arginine was added into the combination as without l-arginine, ceftriaxone and vancomycin get precipitated. Fig. 2 summarizes the results of the FIC index analysis of the various ratios of vancomycin with l-arginine and ceftriaxone tested against clinical isolates of S. aureus, S. epidermidis, S. pneumoniae, E. faecalis, MRSA and hGISA. The results revealed that equal ratio of vancomycin with l-arginine and ceftriaxone was the most synergistic. Further increasing the concentration of ceftriaxone synergistic activity was lost. FIC index study conducted in all selected clinical isolates as well as positive controls and similar findings were obtained. FIC index were 0.375 ± 0.032, 0.285 ± 0.023, 0.238 ± 0.022 0.267 ± 0.021 for positive controls, S. aureus, S. epidermidis, S. pneumoniae and E. faecalis, respectively. From the FIC index data of clinical isolates, FICImin and FICImax were determined and presented in Fig. 3. The FICImin and FICImax were significantly lower equal to less than 0.